<DOC>
	<DOCNO>NCT02704572</DOCNO>
	<brief_summary>The purpose study determine optimal timing zoster vaccination induce high cell-mediated immunity humoral immunity adult patient age 50 history zoster within 5 year .</brief_summary>
	<brief_title>Optimal Timing Zoster Vaccine After Zoster Illness</brief_title>
	<detailed_description>Zoster vaccination recommend FDA adult age 60 year old , approve people age 50 59 year old . For patient shingle , specific length time must wait receive shingle vaccine . It generally recommend patient wait 6 12 month recovery . The investigator plan make scientific recommendation optimal time zoster vaccine zoster illness compare immune response two group ( vaccination 6 month 2 year shingle vs. 2 5 year shingle ) . Primary outcome ELISPOT response week 6 vaccination . Secondary outcome gpELISA titer week 6 vaccination . All patient ask contraindication zoster vaccine physician vaccination . And monitor adverse reaction vaccination 6 week ( visit hospital ) .</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adults age 50 year old shingle 5 year Adults receive zoster vaccination yet Adults understand agree informed consent . Adults condition contraindication zoster vaccine Adults zoster vaccination already Adults take immunosuppressant Human Immunodeficiency Virus ( HIV ) patient whose CD4 T cell count 500/mm3 Adults autoimmune disease anticipate problem immunogenicity vaccine Adults organ transplantation receive immunosuppressant Adults suspect active infectious disease Adults eligible zoster vaccination investigator 's assessment</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Herpes zoster vaccine</keyword>
	<keyword>cell-mediated immunity</keyword>
</DOC>